Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesBetter Regulation of Industry-Sponsored Clinical Trials Is Long Overdue
Journal of Law, Medicine, and Ethics, 09/02/09
Wynia M et al. – Regulating clinical trials for testing new drugs is fraught with risk. Misregulation can slow development of innovative and useful new drugs, but in other ways misregulation can foster trials that are inefficient and unethical, driven by commercial rather than scientific ends, and that can harm patients. Data on industry–funded, late–stage clinical trials demonstrate an urgent need for dramatic changes in how these trials are designed, conducted, and analyzed.
Today in Law/Ethics/Regulations...keeping you current
Receive free subspecialty "5-minute updates" via email
Managing risk to reputation
Clinical Risk, 12/02/09
Cutting through red tape: non-therapeutic circumcision and unethical guidelines
Clinical Ethics, 12/02/09
Aesthetic surgery and regulatory risk for doctors
Clinical Risk, 12/02/09
Article Search
Sponsor